ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 274,48
-0,27%
Dow Jones
42 840,26
1,18%
DAX
19 884,75
-0,57%
Brent Oil
72,72
0,00%
Bitcoin
96 093,08
-1,15%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Biodexa Pharmaceuticals PLC (BDRX) Cours

Biodexa Pharmaceuticals PLC

Biodexa Pharmaceuticals PLC (BDRX)

Non Sponsored BDR Index
3,99
-0,01
(-0,25%)
Fermé 22 Décembre 10:00PM
Retardé de 15 minutes
3,90
-0,09
(-2,26%)
Après les heures de négociation: 1:59AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
3,99
Prix Achat
3,91
Prix Vente
4,80
Volume échangé
24 396
3,90 Fourchette du Jour 4,2151
0,00 Plage de 52 semaines 0,00
Cap du marché
2,318M
Clôture Veille
4,00
Ouverture
4,02
Dernière Transaction
1
@
4.19
Dernière heure de transaction
Volume financier
US$ 99 190
VWAP
4,0658
Volume moyen (3 m)
-
Actions en circulation
580 840
Rendement du Dividende
-
Ratio Cours sur Bénéfices
0,00
Bénéfice par action (BPA)
-
Chiffre d'affairess
381k
Bénéfice net
-7,08M

À propos de Biodexa Pharmaceuticals PLC

Biodexa Pharmaceuticals PLC is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and bio-distribution of medicines. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. Biodexa Pharmaceuticals Q-Sphera technolo... Biodexa Pharmaceuticals PLC is a United Kingdom-based drug delivery technology company. The Company is focused on improving the bio-delivery and bio-distribution of medicines. Its technologies include Biodexa Pharmaceuticals Q-Sphera, MidaCore and MidaSolve. Biodexa Pharmaceuticals Q-Sphera technology focuses on long acting injectables using proprietary 3D printing technology that encapsulates medicines into bioresorbable polymer microspheres with precision characteristics. MidaCore technology platform uses ultra-small gold nanoparticle (GNP) drug conjugates. MidaSolve Nano Inclusion technology solubilizes molecules that have minimal solubility at biological potential of Hydrogen (pH) extending available routes of administration, including direct-to-tumor delivery. It has a pipeline of approximately eight earlier stage programs, MTX110 (Brain Cancer in Children (DIPG)), MTX110 (Medulloblastoma), MTX110 (Glioblastoma), MTX114 (Psoriasis), MTD211 (Schizophrenia, MDD) and others. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Site Web
www.midatechgroup.com
Siège social
Cardiff, Gbr
Fondé
-
Biodexa Pharmaceuticals PLC est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker BDRX. Le dernier cours de clôture d'Biodexa Pharmaceuticals était de US$4,00. Au cours de la dernière année, les actions de Biodexa Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,00 à US$ 0,00.

Biodexa Pharmaceuticals compte actuellement 580 840 actions en circulation. La capitalisation boursière d'Biodexa Pharmaceuticals est de US$2,32 million.

BDRX Dernières nouvelles

Plus de nouvelles

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

04 Décembre 2024
Edgar (US Regulatory)

Result of General Meeting

November 22, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Result of General Meeting Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) (NASDAQ: BDRX), a clinical stage...

22 Novembre 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

12 Novembre 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

12 Novembre 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

12 Novembre 2024
Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]

12 Novembre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

BDRX - Frequently Asked Questions (FAQ)

What is the current Biodexa Pharmaceuticals share price?
The current share price of Biodexa Pharmaceuticals is US$ 3,99
How many Biodexa Pharmaceuticals shares are in issue?
Biodexa Pharmaceuticals has 580 840 shares in issue
What is the market cap of Biodexa Pharmaceuticals?
The market capitalisation of Biodexa Pharmaceuticals is USD 2,32M
What is the 1 year trading range for Biodexa Pharmaceuticals share price?
Biodexa Pharmaceuticals has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Biodexa Pharmaceuticals?
Biodexa Pharmaceuticals reports financial results in GBP
What is the latest annual turnover for Biodexa Pharmaceuticals?
The latest annual turnover of Biodexa Pharmaceuticals is GBP 381k
What is the latest annual profit for Biodexa Pharmaceuticals?
The latest annual profit of Biodexa Pharmaceuticals is GBP -7,08M
What is the registered address of Biodexa Pharmaceuticals?
The registered address for Biodexa Pharmaceuticals is 1 CASPIAN POINT, CASPIAN WAY, CARDIFF, CF10 4DQ
What is the Biodexa Pharmaceuticals website address?
The website address for Biodexa Pharmaceuticals is www.midatechgroup.com
Which industry sector does Biodexa Pharmaceuticals operate in?
Biodexa Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,91M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,75M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,94M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
9,27M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
6,25M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
BDRX
Biodexa Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés